Indications, response, and side effects of biologic treatment in Behçet's disease: an 8-year study with follow-up.
Saeedeh ShenavandehElham AflakiMaryam Rasti JahromiAfshin Borhani HaghighiMohammad Ali NazariniaPublished in: Reumatologia (2024)
We found a promising improvement at 6-month and 12-month follow-ups with various biologic agents in treating Behçet's disease with an acceptable safety profile.